Pancreatic Cancer

Nutrition plays a crucial role in the lives of people with cancer. But more than a million people suffering from the disease in the United States also endure a wasting syndrome called cachexia.

What role will immunotherapy play in the future treatment of GI cancers? CURE spoke to Brian Hemphill, M.D., to find out.

Experimental treatment uses engineered T cells to target prostate stem cell antigen.

A regimen without gemcitabine had promising survival rates for patients with metastatic pancreatic cancer, according to a recent study.

There were promising results when Abraxane was added to standard therapy to treat pancreatic cancer.

CURE spoke with Jason Luke, M.D., about some of the pressing topics in the field of immunotherapy.

A recent study found that taking asprin daily may reduce the chance of developing pancreatic cancer.

Faced with cancer, some launch nonprofit organizations designed to help fellow patients and their families. Here’s how they do it.

Nutrition, though often overlooked, plays a key role in mitigating the symptom burden of patients with pancreatic cancer.

Murray Korc, M.D., of the IUPUI Pancreatic Cancer Signature Center, said that the future holds drastic changes for the treatment of pancreatic cancer.

Patients and providers shared inspiring stories of hope, as well as some tips for better living at the Seventh Annual Ruesch Center Symposium: Fighting a Smarter War on Cancer.

Recent-onset diabetes can lead to poorer outcomes in pancreatic cancer, according to a recent study.

After being diagnosed with pancreatic cancer, a PR executive created on online database where patients can connect with others who share their diagnosis and also get reliable information.

Eileen O'Reilly discusses the current barriers in treating pancreatic cancer, as well as what she sees for the future of the disease.

What can online searches tell about a potential cancer diagnosis? Scientists at Microsoft are interested in finding out.

The addition of Onivyde to some chemotherapy regimens for pancreatic cancer improved survival and did not affect patients' quality of life.

Genetic mutations that were traditionally known for breast and ovarian cancer are now being examined for their role in pancreatic cancer.

Tumor Treating Fields were determined safe to use as a fronline therapy for unresectable pancreatic cancer.

In a phase 3 trial, five-year overall survival was nearly doubled when capecitabine was added to gemcitabine for patients with pancreatic cancer.

Algenpantucel-L failed to improve OS for patients with pancreatic cancer in a phase 3 trial.

Nurses and oncologists need to give portal vein thrombosis a closer look, according to one oncolgy nurse.

In the analysis, there was as much as a 92 percent difference in median overall survival (OS) seen between patients treated in randomized controlled trials and "real world" data.

Scientists are investigating a host of new treatment types that may change the outlook for those with pancreatic cancer.

Thanks to the NPF, patients with pancreatic diseases can now find healthcare organizations that prove excellent in treating their conditions.

Exciting new treatment options for patients with pancreatic cancer are on the rise, thanks to organizations such as the Lustgarten Foundation.